Status:
COMPLETED
Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19.
Lead Sponsor:
National Institute of Cardiology, Laranjeiras, Brazil
Conditions:
Coronavirus Infection
Endothelial Dysfunction
Eligibility:
All Genders
18-80 years
Brief Summary
Considering that the intensity of systemic microvascular changes in patients in the acute phase of COVID-19 could be related to disease progression and prognosis, the present cross-sectional and obser...
Detailed Description
An association between the presence of previous cardiovascular disease and adverse prognosis has been demonstrated in patients with COVID-19 (coronavirus disease-19), presenting increases of up to 5-1...
Eligibility Criteria
Inclusion
- Age\> 18 years admitted to the hospital
- SARS-CoV-2 positive real-time PCR molecular test
- Exclusion Criteria:
- Presence of non-COVID infection with systemic and microbiologically documented repercussions.
Exclusion
Key Trial Info
Start Date :
May 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 10 2022
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04406545
Start Date
May 15 2020
End Date
January 10 2022
Last Update
January 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Cardiology
Rio de Janeiro, Brazil, 21040-360